Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects

Although the detailed pathogenesis of multiple sclerosis (MS) is not completely understood, a broad range of disease-modifying therapies (DMTs) are available. A common side effect of nearly every MS therapeutic agent is lymphopenia, which can be both beneficial and, in some cases, treatment-limiting...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Stefanie, Proschmann, Undine, Akgün, Katja, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625745/
https://www.ncbi.nlm.nih.gov/pubmed/34831400
http://dx.doi.org/10.3390/cells10113177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625745/
https://www.ncbi.nlm.nih.gov/pubmed/34831400
http://dx.doi.org/10.3390/cells10113177

Ejemplares similares